PHBI Share Price Performance
US$0.0024
0.00 (41.18%)
Price US$0.0024
Share Pricen/a
Pharmagreen Biotech Inc. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
PHBI Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Pharmagreen Biotech Inc. Key Details
Last Reported Earnings
Dec 31, 2024
Next Reporting Earnings
n/a
- -0.00034
- 44.90%
- -7,536.88%
- -14.7%
About PHBI
- Founded
- n/a
- Employees
- n/a
- CEO
- WebsiteView website
Pharmagreen Biotech Inc. operates as a nutraceutical company, engages in the formulating products from blends of therapeutic plants and fungi in North America. The company’s primary product is MaxGenomic supplement, a proprietary blend and formulated medicinal mushrooms and medical plants to support the human mind and body. It also provides consulting services for plant genetic selection, tissue culture technologies for starter plantlets production, SOPs for cultivation and live storage of any plant species services. It sells its products through online stores, such as Amazon and Shopify. Pharmagreen Biotech Inc. is headquartered in Coquitlam, Canada.
